Capillary blood tests measure p-tau217, GFAP, and NfL without strict temperature controls or immediate centrifugation. Primary care physicians currently have a diagnostic accuracy of ~61% for ...

Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on costly brain scans or invasive spinal fluid tests to identify the ...

Measurements of phosphorylated tau 217 (p-tau217) in dried plasma spots (DPS) identified people with Alzheimer's disease nearly as well as venous blood, data from the DROP-AD project suggested.

Researchers are examining whether samples collected show accurately certain biomarkers which denote abnormal proteins in the brain. Volunteers in the ongoing study undergo cognitive tests, an MRI and ...

A finger-prick blood test that can be mailed to a lab may offer a simpler way to detect the brain changes linked to Alzheimer’s disease, according to a new study. Researchers tested whether tiny ...

A simple finger-prick dried blood test accurately tracked Alzheimer’s-related brain changes in research settings, pointing to a future role in widening access to early screening while confirmatory ...

An international trial is examining whether a finger-prick blood test could be used to help diagnose Alzheimer's disease. The study, involving 1,000 volunteers aged over 60 in the UK, US and Canada, ...

The research is part of the PREDICTOM study, funded by the Innovative Health Initiative Joint Undertaking (IHI JU). Within this study, researchers are investigating whether biomarkers such as p-Tau217 ...

THE DRIVER OF THE SCDOT TRUCK WAS TICKETED FOR SPEEDING. A NEW DEVELOPMENT IN ALZHEIMER’S AND DEMENTIA RESEARCH PAVES THE WAY FOR AN ACCESSIBLE AND LESS INVASIVE WAY TO DIAGNOSE DECLINING BRAIN ...

Finger-prick blood tests at home detected Alzheimer's biomarkers nearly as well as standard methods. The DROP-AD study suggested that dried blood spots could revolutionize screening approaches for ...